IC2PerMed started on January 1rst, 2020. Get to know the background of this project, its objectives, partners and coming activities
Personalised Medicine (PM) approaches, thanks to the latest technological advances notably in the fields of biomedical and digital technologies, prove their potential to improve healthcare and underpin more efficient and sustainable health systems.
In China it PM attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and producing infrastructures for supporting bioinformatics projects. Turning PM into an opportunity for citizens and patients requires the engagement of stakeholders internationally to define common research and development approaches, standards and priorities.
In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed). The EU-funded IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed of European and Chinese stakeholders towards a common approach of PM, involving policymakers and healthcare beneficiaries.
IC2PerMed project gathers 10 partners from 6 countries, under the lead of the Università Cattolica del Sacro Cuore, gathering expertises from Foundations, European initiative, international association, national centre, universities, and companies from both Chinese and European areas. The project started on January 1rst 2020 and will run over 4 years, for achieving its ambitious goal of making Chinese and international PM research, development and innovation converge towards a common agenda.
IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed consortium of European and Chinese stakeholders towards a common approach of PM research, innovation, development and implementation involving policy makers and healthcare beneficiaries, by:
- mapping policies, programmes, standards and initiatives related to PM in Europe in China for identifying the opportunities for research collaborations;
- structuring its developments upon an ecosystem of European and Chinese experts, collaborating in Working Groups centred on ICPerMed Action plan priorities;
- setting bridges with key organisms involved in the definition and implementation of PM and healthcare systems in both economic areas, both on benefits for coordinated approaches for research and on concrete developments taking place within and along the project;
- inserting its developments in international contexts, through ICPerMed and its involvement in relevant initiatives and networks.